Prostatic soy isoflavone concentrations exceed serum levels after dietary supplementation

Prostate

Volumn 69, Issue 7, 2009, Pages 719-726

  Gardner, Christopher D ^a   Oelrich, Beibei ^a   Liu, Jenny P ^a   Feldman, David ^a   Franke, Adrian A ^b   Brooks, James D ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

Daidzein; Genistein; Prostate cancer; Soy isoflavone

Indexed keywords

AGLYCONE; DAIDZEIN; GENISTEIN; ISOFLAVONE; PLACEBO; EQUOL; ISOFLAVONE DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL; SOYBEAN; ADENOCARCINOMA; BLOOD; COMPARATIVE STUDY; MASS SPECTROMETRY; METABOLISM; NONPARAMETRIC TEST; PROSTATE TUMOR;

ADENOCARCINOMA; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; GENISTEIN; HUMANS; ISOFLAVONES; MALE; MASS SPECTROMETRY; PROSTATIC NEOPLASMS; SOYBEANS; STATISTICS, NONPARAMETRIC;

EID: 65449151910     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.20922     Document Type: Article

References (45)

1. American Cancer Society. Cancer Facts & Figures American Cancer Society 2007. 2007.
2. Kolonel LN, Hankin JH, Whittemore AS, Wu AH, Gallagher RP, Wilkens LR, John EM, Howe GR, Dreon DM, West DW, Paffenbarger RS Jr. Vegetables, fruits, legumes, and prostate cancer: A multiethnic case-control study. Cancer Epidemiol Biomarkers Prev 2000;9(8):795-804.
3. Kurahashi N, Iwasaki M, Sasazuki S, Otani T, Inoue M, Tsugane S. Soy isoflavone consumption is not associated with increased risk of advanced prostate cancer. Cancer Epidemiol Biomarkers Prev 2007;16(10):2169. (Pubitemid 47621199)
4. Yan L, Spitznagel EL. Meta-analysis of soy food and risk of prostate cancer in men. Int J Cancer 2005;117(4):667-669. (Pubitemid 41504557)
5. Messina MJ. Emerging evidence on the role of soy in reducing prostate cancer risk. Nutr Rev 2003;61(4):117-131. (Pubitemid 37255289)
6. Marks LS, Kojima M, Demarzo A, Heber D, Bostwick DG, Qian J, Dorey FJ, Veltri RW, Mohler JL, Partin AW. Prostate cancer in native Japanese and Japanese-American men: Effects of dietary differences on prostatic tissue. Urology 2004;64(4):765-771.
7. Bektic J, Berger AP, Pfeil K, Dobler G, Bartsch G, Klocker H. Androgen receptor regulation by physiological concentrations of the isoflavonoid genistein in androgen-dependent LNCaP cells is mediated by estrogen receptor beta. Eur Urol 2004;45(2):245-251. (Pubitemid 38147834)
8. Chang YC, Nair MG, Nitiss JL. Metabolites of daidzein and genistein and their biological activities. J Nat Prod 1995;58(12):1901-1905.
9. Davis JN, Kucuk O, Sarkar FH. Expression of prostate-specific antigen is transcriptionally regulated by genistein in prostate cancer cells. Mol Carcinog 2002;34(2):91-101. (Pubitemid 34606511)
10. Davis JN, Kucuk O, Sarkar FH. Genistein inhibits NF-kappa B activation in prostate cancer cells. Nutr Cancer 1999;35(2):167-174. (Pubitemid 30115128)
11. Kang NJ, Lee KW, Rogozin EA, Cho YY, Heo YS, Bode AM, Lee HJ, Dong Z. Equol, a metabolite of the soybean isoflavone daidzein, inhibits neoplastic cell transformation by targeting the MEK/ERK/p90RSK/activator protein-1 pathway. J Biol Chem 2007;282(45):32856-32866. (Pubitemid 350159319)
12. Kikuno N, Shiina H, Urakami S, Kawamoto K, Hirata H, Tanaka Y, Majid S, Igawa M, Dahiya R. Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells. Int J Cancer 2008;123(3):552-560.
13. Lakshman M, Xu L, Ananthanarayanan V, Cooper J, Takimoto CH, Helenowski I, Pelling JC, Bergan RC. Dietary genistein inhibits metastasis of human prostate cancer in mice. Cancer Res 2008;68(6):2024-2032.
14. Lazarevic B, Karlsen SJ, Saatcioglu F. Genistein differentially modulates androgen-responsive gene expression and activates JNK in LNCaP cells. Oncol Rep 2008;19(5):1231-1235.
15. Majid S, Kikuno N, Nelles J, Noonan E, Tanaka Y, Kawamoto K, Hirata H, Li LC, Zhao H, Okino ST, Place RF, Pookot D, Dahiya R. Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification. Cancer Res 2008;68(8):2736-2744.
16. Verma SP, Goldin BR. Effect of soy-derived isoflavonoids on the induced growth of MCF-7 cells by estrogenic environmental chemicals. Nutr Cancer 1998;30(3):232-239. (Pubitemid 28289567)
17. Lo FH, Mak NK, Leung KN. Studies on the anti-tumor activities of the soy isoflavone daidzein on murine neuroblastoma cells. Biomedicine and pharmacotherapy 2007;61(9):591-595. (Pubitemid 47562698)
18. Lund TD, Munson DJ, Haldy ME, Setchell KD, Lephart ED, Handa RJ. Equol is a novel anti-androgen that inhibits prostate growth and hormone feedback. Biol Reprod 2004;70(4):1188-1195. (Pubitemid 38387732)
19. Joniau S, Goeman L, Roskams T, Lerut E, Oyen R, Van Poppel H. Effect of nutritional supplement challenge in patients with isolated high-grade prostatic intraepithelial neoplasia. Urology 2007;69(6):1102-1106. (Pubitemid 46891599)
20. Hamilton-Reeves JM, Rebello SA, Thomas W, Kurzer MS, Slaton JW. Effects of soy protein isolate consumption on prostate cancer biomarkers in men with HGPIN, ASAP, and low-grade prostate cancer. Nutr Cancer 2008;60(1):7-13.
21. Hussain M, Banerjee M, Sarkar FH, Djuric Z, Pollak MN, Doerge D, Fontana J, Chinni S, Davis J, Forman J, Wood DP, Kucuk O. Soy isoflavones in the treatment of prostate cancer. Nutr Cancer 2003;47(2):111-117. (Pubitemid 38590881)
22. Spentzos D, Mantzoros C, Regan MM, Morrissey ME, Duggan S, Flickner-Garvey S, McCormick H, DeWolf W, Balk S, Bubley GJ. Minimal effect of a low-fat/high soy diet for asymptomatic, hormonally naive prostate cancer patients. Clin Cancer Res 2003;9(9):3282-3287. (Pubitemid 37082721)
23. Vaishampayan U, Hussain M, Banerjee M, Seren S, Sarkar FH, Fontana J, Forman JD, Cher ML, Powell I, Pontes JE, Kucuk O. Lycopene and soy isoflavones in the treatment of prostate cancer. Nutr Cancer 2007;59(1):1-7. (Pubitemid 47549774)
24. Perabo FG, Von Low EC, Ellinger J, von Rucker A, Muller SC, Bastian PJ. Soy isoflavone genistein in prevention and treatment of prostate cancer. Prostate Cancer Prostatic Dis 2008;11(1):6-12.
25. Manach C, Williamson G, Morand C, Scalbert A, Remesy C. Bioavailability and bioefficacy of polyphenols in humans I. Review of 97 bioavailability studies. Am J Clin Nutr 2005;81(1 Suppl):230S-242S.
26. Williamson G, Manach C. Bioavailability and bioefficacy of polyphenols in humans II. Review of 93 intervention studies. Am J Clin Nutr 2005;81(1 Suppl):243S-255S.
27. Hedlund TE, Maroni PD, Ferucci PG, Dayton R, Barnes S, Jones K, Moore R, Ogden LG, Wahala K, Sackett HM, Gray KJ. Long-term dietary habits affect soy isoflavone metabolism and accumulation in prostatic fluid in caucasian men. J Nutr 2005;135(6):1400-1406. (Pubitemid 40799602)
28. Zava DT, Duwe G. Estrogenic and anti-proliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer 1997;27(1):31-40. (Pubitemid 26424313)
29. Swami S, Krishnan AV, Peehl DM, Feldman D. Genistein potentiates the growth inhibitory effects of 1,25-dihydroxyvitamin D3 in DU145 human prostate cancer cells: Role of the direct inhibition of CYP24 enzyme activity. Mol Cell Endocrinol 2005;241(1-2):49-61.
30. Nielsen IL, Williamson G. Review of the factors affecting bioavailability of soy isoflavones in humans. Nutr Cancer 2007;57(1):1-10. (Pubitemid 46871564)
31. Farhan H, Wahala K, Adlercreutz H, Cross HS. Isoflavonoids inhibit catabolism of vitamin D in prostate cancer cells. J Chromatogr 2002;777(1-2):261-268. (Pubitemid 35257876)
32. Brossner C, Petritsch K, Fink K, Auprich M, Madersbacher S, Adlercreutz H, Rehak P, Petritsch P. Phytoestrogen tissue levels in benign prostatic hyperplasia and prostate cancer and their association with prostatic diseases. Urology 2004;64(4):707-711. (Pubitemid 39446048)
33. Guy L, Vedrine N, Urpi-Sarda M, Gil-Izquierdo A, Al-Maharik N, Boiteux JP, Scalbert A, Remesy C, Botting NP, Manach C. Orally administered isoflavones are present as glucuronides in the human prostate. Nutr Cancer 2008;60(4):461-468.
34. Hong SJ, Kim SI, Kwon SM, Lee JR, Chung BC. Comparative study of concentration of isoflavones and lignans in plasma and prostatic tissues of normal control and benign prostatic hyperplasia. Yonsei Med J 2002;43(2):236-241. (Pubitemid 34498427)
35. Rannikko A, Petas A, Rannikko S, Adlercreutz H. Plasma and prostate phytoestrogen concentrations in prostate cancer patients after oral phytoestogen supplementation. Prostate 2006;66(1):82-87. (Pubitemid 43005951)
36. Gardner CD, Chatterjee LM, Franke AA. Effects of isoflavone supplements versus soy foods on blood concentrations of genistein and daidzein in adults. J Nutr Biochem 2008. [Epub ahead of print].
37. Swami S, Krishnan AV, Moreno J, Bhattacharyya RB, Peehl DM, Feldman D. Calcitriol and genistein actions to inhibit the prostaglandin pathway: Potential combination therapy to treat prostate cancer. J Nutr 2007;137(1 Suppl):205S-210S.
38. Heald CL, Ritchie MR, Bolton-Smith C, Morton MS, Alexander FE. Phyto-oestrogens and risk of prostate cancer in Scottish men. Br J Nutr 2007;98(2):388-396. (Pubitemid 47091381)
39. Izumi T, Piskula MK, Osawa S, Obata A, Tobe K, Saito M, Kataoka S, Kubota Y, Kikuchi M. Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. J Nutr 2000;130(7):1695-1699. (Pubitemid 30451055)
40. Watanabe S, Yamaguchi M, Sobue T, Takahashi T, Miura T, Arai Y, Mazur W, Wahala K, Adlercreutz H. Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako). J Nutr 1998;128(10):1710-1715. (Pubitemid 28452856)
41. Wiseman H, Casey K, Bowey EA, Duffy R, Davies M, Rowland IR, Lloyd AS, Murray A, Thompson R, Clarke DB. Influence of 10 wk of soy consumption on plasma concentrations and excretion of isoflavonoids and on gut microflora metabolism in healthy adults. Am J Clin Nutr 2004;80(3):692-699. (Pubitemid 41115535)
42. Messina M, Nagata C, Wu AH. Estimated Asian adult soy protein and isoflavone intakes. Nutr Cancer 2006;55(1):1-12. (Pubitemid 44477039)
43. Morton MS, Chan PS, Cheng C, Blacklock N, Matos-Ferreira A, Abranches-Monteiro L, Correia R, Lloyd S, Griffiths K. Lignans and isoflavonoids in plasma and prostatic fluid in men: Samples from Portugal, Hong Kong, and the United Kingdom. Prostate 1997;32(2):122-128.
44. Franke AA, Custer LJ, Hundahl SA. Determinants for urinary and plasma isoflavones in humans after soy intake. Nutr Cancer 2004;50(2):141-154.
45. Swami S, Krishnan AV, Moreno J, Bhattacharyya RS, Gardner C, Brooks JD, Peehl DM, Feldman D. Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients. Int J Cancer. 2008 [Epub ahead of print]